Michael Bigham

Companies

• Paratek Pharmaceuticals, Inc.Chair Nov 3, 2014 to Sep 21, 2023¹
• Frazier Lifesciences Acquisition CorpBoard member Dec 8, 2020 to Nov 23, 2022²
• Adamas Pharmaceuticals (United States)Board member Sep 22, 2016 to Nov 24, 2021³
• Paratek Pharmaceuticals, Inc.Board member Oct 8, 2019 to Feb 21, 2020⁴
• Paratek Pharmaceuticals, Inc.Chief executive officer Nov 3, 2014 to Feb 28, 2019¹
• SUPERNUS PHARMACEUTICALS, INC.Board member Apr 30, 2012 to Mar 26, 2013⁵

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• PPParatek Pharmaceuticals, Inc.0 shares⁶Sep 21, 2023
• APAdamas Pharmaceuticals (United States)0 shares⁷Nov 24, 2021

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 21, 2023Returned to company 228,750 shares of Paratek Pharmaceuticals, Inc.⁶
• Sep 21, 2023Returned to company 1,129,282 shares of Paratek Pharmaceuticals, Inc.⁶
• Aug 9, 2023Sold 31,250 shares at $2.20 of Paratek Pharmaceuticals, Inc.⁸
• Aug 8, 2023Granted 156,250 shares of Paratek Pharmaceuticals, Inc.⁸
• Dec 21, 2022Sold 15,750 shares at $1.99 of Paratek Pharmaceuticals, Inc.⁹
• Dec 20, 2022Granted 45,000 shares of Paratek Pharmaceuticals, Inc.⁹
• Dec 13, 2022Sold 31,891 shares at $1.96 of Paratek Pharmaceuticals, Inc.¹⁰
• Dec 12, 2022Sold 19,484 shares at $1.98 of Paratek Pharmaceuticals, Inc.¹⁰
• Oct 28, 2022Sold 6,000 shares at $3.47 of Paratek Pharmaceuticals, Inc.¹¹
• Oct 25, 2022Granted 30,000 shares of Paratek Pharmaceuticals, Inc.¹²
• Aug 9, 2022Sold 28,637 shares at $2.66 of Paratek Pharmaceuticals, Inc.¹³
• Aug 8, 2022Granted 143,182 shares of Paratek Pharmaceuticals, Inc.¹³
• Mar 15, 2022Granted 202,500 shares of Paratek Pharmaceuticals, Inc.¹⁴
• Dec 15, 2021Sold 17,819 shares at $4.27 of Paratek Pharmaceuticals, Inc.¹⁵
• Dec 14, 2021Sold 8,622 shares at $4.37 of Paratek Pharmaceuticals, Inc.¹⁵
• Dec 13, 2021Sold 5,059 shares at $4.42 of Paratek Pharmaceuticals, Inc.¹⁵
• Nov 24, 2021U 10,000 shares of Adamas Pharmaceuticals (United States)⁷
• Feb 2, 2018Exercised options 23,255 shares at $4.30 of Paratek Pharmaceuticals, Inc.⁶